What are the risks, negative side effects, and potential long‑term damage associated with the EMSella chair?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

EMSella Chair Safety Profile

EMSella therapy demonstrates a favorable safety profile with minimal adverse effects and no documented long-term damage in the available evidence. The most recent comparative study shows that EMSella is actually safer than surgical alternatives, with fewer complications and no serious adverse events reported 1.

Short-Term Side Effects

Based on the 2025 prospective comparative study, EMSella therapy shows:

  • Minimal infection risk (lower than surgical comparators)
  • No dyspareunia (sexual dysfunction), unlike surgical alternatives
  • Rapid recovery with 91% of patients resuming daily activities within one week 1

The study comparing EMSella to anterior colporrhaphy surgery found that EMSella had a "better safety profile" with fewer complications overall 1.

Long-Term Concerns

There is no evidence of long-term tissue damage or permanent adverse effects from EMSella therapy. The main limitation is not safety-related but rather efficacy:

  • Higher recurrence rates compared to surgery (31% vs. 14% at one year) 1
  • Less durable anatomical correction (64% vs. 88% achieving optimal outcomes) 1

This means patients may need repeat treatments rather than experiencing harm from the therapy itself.

Theoretical Considerations from Electromagnetic Muscle Stimulation

While the evidence specifically on EMSella is limited, neuromuscular electrical stimulation (NMES) research provides context on electromagnetic muscle stimulation mechanisms:

  • Muscle soreness and damage can occur, particularly early in treatment, even at low contraction levels 2
  • This includes delayed onset muscle soreness (DOMS) and temporary elevation of creatine kinase
  • However, a "repeated bout effect" occurs where subsequent sessions cause much less soreness and damage 2
  • These effects are temporary repair mechanisms, not permanent damage 2

Clinical Bottom Line

Patients should not be concerned about long-term damage from EMSella. The therapy's main drawback is that it may be less effective long-term than surgical options for anatomical correction, requiring maintenance treatments. The side effects are mild, temporary, and resolve without intervention. EMSella is particularly appropriate for patients seeking non-invasive treatment, those with surgical contraindications, or those with milder symptoms 1.

Common Pitfalls to Avoid

  • Don't confuse lack of long-term efficacy with long-term harm—these are different issues
  • Patients may experience mild discomfort during initial sessions, which typically improves with subsequent treatments
  • Set realistic expectations: EMSella may require ongoing maintenance rather than providing permanent correction

References

Related Questions

What is EMsella therapy, including its indications, contraindications, treatment protocol, and recommended next steps if it fails?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
Between losartan and amlodipine, which medication is more likely to cause dizziness?
Which phosphate binders are available in powder form for an end‑stage renal disease (ESRD) patient?
What physical‑therapy program should be recommended for a patient with levoconvex scoliosis centered at L4 and advanced asymmetric degenerative changes on the concave side of the curve?
What is the recommended timeline for rabies post‑exposure prophylaxis, including wound cleaning, rabies immune globulin administration, and vaccine dosing?
In a pregnant woman with dysuria and a negative urine dipstick, what is the appropriate evaluation and management?
What is the recommended dosing and monitoring for initiating risperidone (Risperdal) 0.25 mg daily in a child/adolescent with oppositional defiant disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.